Pfizer and BioNTech announced Monday morning that one of its vaccine candidates has a more than 90% effectiveness in preventing COVID-19.
“Today is a great day for science and humanity,” said Pfizer CEO Alberta Bourla. “The first set of results from our Phase 3 COVID-19 vaccine trial provides the initial evidence of our vaccine’s ability to prevent COVID-19.”
Recommended Stories
Print subscriber? Click here to login/register your account
Digital subscriber? Click here to login/register your account.